Qualifikation

Leiter Uroonkologie und Diagnostik, Prostatakarzinom-Zentrumskoordinator, Facharzt für Urologie, Fellow of the European Board of Urology (FEBU); Palliativmediziner, medikamentöser Tumortherapie und genetische Beratung

Ermächtigungsumfang

Auf Überweisung von Vertragsärzten für Urologie:

Konsiliaruntersuchung bei Prostataerkrankungen zur Abklärung der Frage, ob eine stationäre Behandlung in der Urologischen Klinik der Städtischen Klinikum Braunschweig gGmbH, Salzdahlumer Str. 90, möglich und medizinisch indiziert ist.

01321, 01602, 26341, 33043 ,33090, 40120.

Ermächtigung ambulante Versorgung

Mitgliedschaften

European Association of Urology (EAU)
American Urological Association (AUA)
Deutsche Gesellschaft für Urologie (DGU)
Vereinigung Norddeutscher Urologen (VNU)

Publikationen

Schiffmann J, Karakiewicz PI, Rink M, Manka L, Salomon G, Tilki D, Budäus L, Pompe R, Leyh-Bannurah SR, Haese A, Hammerer P, Huland H, Graefen M, Tennstedt P.
Obesity paradox in prostate cancer: increased body mass index was associated with decreased risk of metastases after surgery in 13,667 patients.
World J Urol. 2018 Jul;36(7):1067-1072. doi: 10.1007/s00345-018-2240-8. Epub 2018 Mar 2. PubMed PMID: 29497861.

Schiffmann J, Grindei M, Tian Z, Yassin DJ, Steinwender T, Leyh-Bannurah SR, Randazzo M, Kwiatkowski M, Karakiewicz PI, Hammerer P, Manka L.
Limitations of Elastography Based Prostate Biopsy.
J Urol. 2016 Jun;195(6):1731-6. doi: 10.1016/j.juro.2015.12.086. Epub 2016 Jan 6. PubMed PMID: 26767519.

Randazzo M, Müller A, Carlsson S, Eberli D, Huber A, Grobholz R, Manka L, Mortezavi A, Sulser T, Recker F, Kwiatkowski M.
A positive family history as a risk factor for prostate cancer in a population-based study with organised prostate-specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau).
BJU Int. 2016 Apr;117(4):576-83. doi: 10.1111/bju.13310. Epub 2015 Oct 6. PubMed PMID: 26332304; PubMed Central PMCID: PMC4955666.

Schiffmann J, Mehring G, Tennstedt P, Manka L, Boehm K, Leyh-Bannurah SR, Karakiewicz PI, Hammerer P, Graefen M, Salomon G.
True targeting-derived prostate biopsy: HistoScanning™ remained inadequate despite advanced technical efforts.
World J Urol. 2016 Apr;34(4):495-500. doi: 10.1007/s00345-015-1637-x. Epub 2015 Jul 28. PubMed PMID: 26215749.

Sooriakumaran P, Karnes J, Stief C, Copsey B, Montorsi F, Hammerer P, Beyer B, Moschini M, Gratzke C, Steuber T, Suardi N, Briganti A, Manka L, Nyberg T, Dutton SJ, Wiklund P, Graefen M.
A Multi-institutional Analysis of Perioperative Outcomes in 106 Men Who Underwent Radical Prostatectomy for Distant Metastatic Prostate Cancer at Presentation.
Eur Urol. 2016 May;69(5):788-94. doi: 10.1016/j.eururo.2015.05.023. Epub 2015 May 30. PubMed PMID: 26038098.

Schiffmann J, Manka L, Boehm K, Leyh-Bannurah SR, Karakiewicz PI, Graefen M, Hammerer P, Salomon G.
Controversial evidence for the use of HistoScanning™ in the detection of prostate cancer.
World J Urol. 2015 Dec;33(12):1993-9. doi: 10.1007/s00345-015-1555-y. Epub 2015 Apr 10. Review. PubMed PMID: 25860379.

Randazzo M, Beatrice J, Huber A, Grobholz R, Manka L, Chun FK, Kluth LA, Wyler SF, Recker F, Kwiatkowski M.
Is further screening of men with baseline PSA < 1 ng ml(-1) worthwhile? The discussion continues-Results of the Swiss ERSPC (Aarau).
Int J Cancer. 2015 Aug 1;137(3):553-9. doi: 10.1002/ijc.29420. Epub 2015 Jan 23. PubMed PMID: 25565393.

Kwiatkowski M, Randazzo M, Kluth L, Manka L, Huber A, Recker F.
Prostate cancer screening: and yet it moves!
Asian J Androl. 2015 May-Jun;17(3):437-8. doi: 10.4103/1008-682X.143310. PubMed PMID: 25532573; PubMed Central PMCID: PMC4430944.

Randazzo M, Beatrice J, Huber A, Grobholz R, Manka L, Chun FK, Recker F, Kwiatkowski M.
A "PSA pyramid" for men with initial prostate-specific antigen ≤3 ng/ml: a plea for individualized prostate cancer screening.
Eur Urol. 2015 Oct;68(4):591-7. doi: 10.1016/j.eururo.2014.04.005. Epub 2014 Apr 18. PubMed PMID: 24794075.